Risks and benefits of multiple sclerosis therapies: Need for continual assessment?

Bernd C. Kieseier, Heinz Wiendl, Hans Peter Hartung, Verena Isabell Leussink, Olaf Stüve

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Risks and benefits of multiple sclerosis therapies: Need for continual assessment?'. Together they form a unique fingerprint.

Medicine & Life Sciences